BioSpace News Archive

Press Releases

Ensho Therapeutics Announces Upcoming Presentation at ECCO 2025 of Phase 1, Once-Daily Dosing Data for NSHO-101, an Oral α4β7 Inhibitor for Inflammatory Bowel Disease

February 17, 2025
·
2 min read
Press Releases

IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML

February 17, 2025
·
7 min read
Press Releases

Aramis Biotechnologies and the Biologics Manufacturing Centre Announce a Partnership

February 17, 2025
·
2 min read
Press Releases

UroGen Announces Results from Subgroup Analyses of the Pivotal ENVISION Trial Evaluating Impact of Baseline Tumor Burden and Focality on Response to UGN-102

February 17, 2025
·
9 min read
Press Releases

FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

February 17, 2025
·
3 min read
Press Releases

Edesa Biotech Reports Fiscal 1st Quarter 2025 Results

February 17, 2025
·
9 min read
Press Releases

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 14, 2025

February 17, 2025
·
3 min read
Press Releases

Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

February 17, 2025
·
11 min read
Press Releases

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025

February 17, 2025
·
9 min read
Press Releases

U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)

February 17, 2025
·
10 min read